Lundbeck Inc. has recalled two lots of NeoProfen (ibuprofen lysine) that failed to meet a visible particulate quality requirement. NeoProfen is used to close a clinically significant patent ductus arteriosus (PDA) in premature infants. Read more here.
© 2020 HealthCom Media
All rights reserved. No part of this website or publication may be reproduced, stored, or transmitted in any form or by any means, electronic or mechanical, including photocopy, recording, or any information storage and retrieval system, without permission in writing from the copyright holder